TY - JOUR
T1 - Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells
AU - Mansouri, Mandana
AU - Douglas, Janet
AU - Rose, Patrick P.
AU - Gouveia, Kristine
AU - Thomas, Gary
AU - Means, Robert E.
AU - Moses, Ashlee V.
AU - Früh, Klaus
PY - 2006/9/15
Y1 - 2006/9/15
N2 - The transmembrane ubiquitin ligase K5/MIR2 of Kaposi sarcoma herpesvirus (KSHV) mediates internalization and lysosomal degradation of glycoproteins involved in antigen presentation and costimulation. In endothelial cells (ECs), K5 additionally reduced expression of CD31/platelet-endothelial cell adhesion molecule (PECAM), an adhesion molecule regulating cell-cell interactions of ECs, platelets, monocytes, and T cells. K5 also reduced EC migration, a CD31-dependent process. Unlike other K5 substrates, both newly synthesized and pre-existing CD31 molecules were targeted by K5. K5 was transported to the cell surface and ubiquitinated pre-existing CD31, resulting in endocytosis and lysosomal degradation. In the endoplasmic reticulum, newly synthesized CD31 was degraded by proteasomes, which required binding of phosphofurin acidic cluster sorting protein-2 (PACS-2) to acidic residues in the carboxyterminal tail of K5. Thus, CD31, a novel target of K5, is efficiently removed from ECs by a dual degradation mechanism that is regulated by the subcellular sorting of the ubiquitin ligase. K5-mediated degradation of CD31 is likely to affect EC function in KS tumors.
AB - The transmembrane ubiquitin ligase K5/MIR2 of Kaposi sarcoma herpesvirus (KSHV) mediates internalization and lysosomal degradation of glycoproteins involved in antigen presentation and costimulation. In endothelial cells (ECs), K5 additionally reduced expression of CD31/platelet-endothelial cell adhesion molecule (PECAM), an adhesion molecule regulating cell-cell interactions of ECs, platelets, monocytes, and T cells. K5 also reduced EC migration, a CD31-dependent process. Unlike other K5 substrates, both newly synthesized and pre-existing CD31 molecules were targeted by K5. K5 was transported to the cell surface and ubiquitinated pre-existing CD31, resulting in endocytosis and lysosomal degradation. In the endoplasmic reticulum, newly synthesized CD31 was degraded by proteasomes, which required binding of phosphofurin acidic cluster sorting protein-2 (PACS-2) to acidic residues in the carboxyterminal tail of K5. Thus, CD31, a novel target of K5, is efficiently removed from ECs by a dual degradation mechanism that is regulated by the subcellular sorting of the ubiquitin ligase. K5-mediated degradation of CD31 is likely to affect EC function in KS tumors.
UR - http://www.scopus.com/inward/record.url?scp=33748695504&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748695504&partnerID=8YFLogxK
U2 - 10.1182/blood-2005-11-4404
DO - 10.1182/blood-2005-11-4404
M3 - Article
C2 - 16601245
AN - SCOPUS:33748695504
SN - 0006-4971
VL - 108
SP - 1932
EP - 1940
JO - Blood
JF - Blood
IS - 6
ER -